RubyHealth
App Plan
Mission
Give patients and doctors clear monitoring and confidential communication so clinicians can make better-informed decisions from RubyHealth data.
About us
A health application for monitoring and doctor–patient communication.
RubyHealth helps patients and families capture a clear health record, and helps authorised doctors review that record and communicate confidentially — so clinical decisions can be made with better data. We are in beta testing, with a planned Q4 2026 launch.
Mission, vision, and values.
Device readings, paper diaries, medication changes, and short appointment windows leave a fragmented picture. RubyHealth organises those signals in one timeline and keeps communication between the patient (or family) and their doctor in the same place.
The product is not a diagnostic tool. It is a monitoring and communication aid that respects medical judgement.
Vision
One health application for longitudinal records across care pathways, starting with PANS/PANDAS.
Values
Careful claims, practical design, POPIA-aware sharing, and research-minded iteration.
How people capture data
Xiaomi watch now. Phone app always. Other wearables later.
The current trial watch is the Xiaomi Watch 2, paired with the Ruby Mobile Health App. A watch is optional: families can log from the phone alone. We are not limited to one watch brand — other wearables can be added as they are tested.
First product offering
PANS / PANDAS is the first pathway on RubyHealth.
The first service we are rolling out is a monitoring trial for families and clinicians working with PANS and PANDAS (Pediatric Autoimmune Neuropsychiatric Disorders Associated with Streptococcal Infections) and related rapid-onset patterns. Fifty patients are lined up for this trial. The same application — tracking, journal, and confidential doctor chat — is built so other care pathways can follow without becoming a different product.
Meet the team
People behind the RubyHealth direction.
Research partners
Built for careful collaboration.
RubyHealth is relevant to partners working with paediatric, neurodiverse, neuroimmune, and other longitudinal care pathways. Educational content (including PANS/PANDAS) is labelled carefully and kept separate from diagnosis or treatment guidance.